Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ALGM
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio 6.15 4.85 4.57
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -14.36 0.88 1.02
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value -0.55 5.85 5.89
Cash 3.44 1.15 1.11
Capex 58.60 -0.07 -0.18
Free Cash Flow -99.85 < 0.005 0.20
Revenue -5.85 1.25 1.32
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -2.37 0.51 0.52
Operating Margin 11.81 0.16 0.14
ROA -78.91 < 0.005 0.02
ROE -78.59 < 0.005 0.03
ROIC -52.18 -0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALGM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALGM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALGM is permitted for members.